\-\ Texto\\:\\ \ \(0\)\
\-\ abdominal\\ distension\\,\\ elevated\\ circulating\\ estrogens\ \(0\)\
\-\ \\â\\€\\¢\\	surgical\\ resection\\ as\\ possible\\-\\ many\\ lesions\\ will\\ be\\ surgically\\ unresectable\\ or\\ inaccessible\\ such\\ as\\ at\\ the\\ mesenteric\\ root\\ \ \(0\)\
\-\ \\â\\€\\¢\\	surgical\\ v\\.\\ chemical\\ castration\\ \\(gnrh\\ analogues\\)\ \(0\)\
\-\ \\â\\€\\¢\\	aromatase\\ inhibitors\\ \\(anastrozole\\)\ \(0\)\
\-\ \\â\\€\\¢\\	goal\\-\\ symptomatic\\ improvement\ \(0\)\
\-\ \\â\\€\\¢\\	metastatic\\ degeneration\\ to\\ sarcoma\\-\\ only\\ 2\\-3\\ case\\ reports\\ in\\ literature\ \(0\)\
\-\ sagittal\\ t\\-2\\ weighted\\ and\\ axial\\ t\\-2\\ weighted\\ with\\ fat\\ suppression\\ mr\\ images\\ of\\ the\\ pelvis\\ demonstrate\\ multiple\\ subserosal\\ and\\ intramural\\ uterine\\ fibroids\\ with\\ too\\ numerous\\ to\\ count\\ intraperitoneal\\ masses\\ of\\ similar\\ homogenous\\ hypointensity\ \(0\)\
\-\ disseminated\\ peritoneal\\ leiomyomatosis\ \(0\)\
\-\ disseminated\\ peritoneal\\ leiomyomatosis\ \(0\)\
\-\ metastatic\\ peritoneal\\ leiomyomatosis\ \(0\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ peritoneal\\ carcinomatosis\\ from\\ ovarian\\ or\\ other\\ source\\.\ \(0\)\
\-\ 40\\ year\\ old\\ woman\\ with\\ a\\ fibroid\\ uterus\\,\\ abdominal\\ fullness\\ and\\ urinary\\ frequency\\.\ \(1\)\
\-\ \\â\\€\\¢\\	takeda\\ t\\,\\ masuhara\\ k\\,\\ kamiura\\ s\\.\\ \\ successful\\ management\\ of\\ a\\ leiomyomatosis\\ peritonealis\\ disseminata\\ with\\ an\\ aromatase\\ inhibitor\\.\\ obstet\\ gynecol\\.\\ 2008\\ aug\\;112\\(2\\ pt\\ 2\\)\\:491\\-3\\.\ \(0\)\
\-\ \\â\\€\\¢\\	ueda\\ h\\,\\ togashi\\ k\\,\\ konishi\\ i\\ et\\ al\\.\\ unusual\\ appearances\\ of\\ uterine\\ leiomyomas\\:\\ mr\\ imaging\\ findings\\ and\\ their\\ histopathologic\\ backgrounds\\.\\ radiographics\\ 1999\\;\\ 19\\:\\ 131\\-45\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leiomyomatosis\\:\\ 0\\.16332076476821986\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0940967316719466\ \(0\)\
\-\ aromatase\\:\\ 0\\.09328590924832272\ \(0\)\
\-\ t\\-2\\:\\ 0\\.08166038238410993\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.05803756857762547\ \(0\)\
\-\ disseminated\\:\\ 0\\.05507513768594998\ \(0\)\
\-\ k\\:\\ 0\\.04927656445086588\ \(0\)\
\-\ estrogens\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ possible\\-\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ inaccessible\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ analogues\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ anastrozole\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ goal\\-\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ sarcoma\\-\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ takeda\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ masuhara\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ kamiura\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ peritonealis\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ disseminata\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ \\:491\\-3\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ ueda\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ togashi\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ konishi\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ backgrounds\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ 131\\-45\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ uterine\\:\\ 0\\.046398958996012526\ \(0\)\
\-\ castration\\:\\ 0\\.04297550922437329\ \(0\)\
\-\ gnrh\\:\\ 0\\.04297550922437329\ \(0\)\
\-\ obstet\\:\\ 0\\.040830191192054964\ \(0\)\
\-\ gynecol\\:\\ 0\\.040830191192054964\ \(0\)\
\-\ weighted\\:\\ 0\\.039319068742246555\ \(0\)\
\-\ 112\\:\\ 0\\.03812741011392803\ \(0\)\
\-\ unresectable\\:\\ 0\\.037162745792266895\ \(0\)\
\-\ subserosal\\:\\ 0\\.037162745792266895\ \(0\)\
\-\ circulating\\:\\ 0\\.036347133729688806\ \(0\)\
\-\ leiomyomas\\:\\ 0\\.035640618424797155\ \(0\)\
\-\ aug\\:\\ 0\\.03501742775994856\ \(0\)\
\-\ histopathologic\\:\\ 0\\.03445996471413996\ \(0\)\
\-\ v\\.\\:\\ 0\\.03349530039247882\ \(0\)\
\-\ inhibitors\\:\\ 0\\.03349530039247882\ \(0\)\
\-\ appearances\\:\\ 0\\.03307179400267175\ \(0\)\
\-\ inhibitor\\:\\ 0\\.03231464668182163\ \(0\)\
\-\ suppression\\:\\ 0\\.030792519314351886\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.02982785499269075\ \(0\)\
\-\ fibroids\\:\\ 0\\.029012242930112665\ \(0\)\
\-\ intramural\\:\\ 0\\.028826574571322875\ \(0\)\
\-\ mr\\:\\ 0\\.02873226954440671\ \(0\)\
\-\ hypointensity\\:\\ 0\\.028647201282033557\ \(0\)\
\-\ fibroid\\:\\ 0\\.027984962430425062\ \(0\)\
\-\ chemical\\:\\ 0\\.02783158921945547\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.027682536960372425\ \(0\)\
\-\ intraperitoneal\\:\\ 0\\.026866924897794336\ \(0\)\
\-\ homogenous\\:\\ 0\\.026866924897794336\ \(0\)\
\-\ s\\.\\:\\ 0\\.026501883249715228\ \(0\)\
\-\ radiographics\\:\\ 0\\.026501883249715228\ \(0\)\
\-\ distension\\:\\ 0\\.026271803292362114\ \(0\)\
\-\ 2008\\:\\ 0\\.026160409592902684\ \(0\)\
\-\ fullness\\:\\ 0\\.02583964439810673\ \(0\)\
\-\ 1999\\:\\ 0\\.02563611910272157\ \(0\)\
\-\ too\\:\\ 0\\.025344797530324596\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.02439590372791287\ \(0\)\
\-\ literature\\:\\ 0\\.02431751703063699\ \(0\)\
\-\ successful\\:\\ 0\\.02408909284087398\ \(0\)\
\-\ source\\:\\ 0\\.02387012344318692\ \(0\)\
\-\ frequency\\:\\ 0\\.02387012344318692\ \(0\)\
\-\ h\\:\\ 0\\.023799102171588295\ \(0\)\
\-\ root\\:\\ 0\\.023326979770911346\ \(0\)\
\-\ degeneration\\:\\ 0\\.0229533418491444\ \(0\)\
\-\ surgically\\:\\ 0\\.022893555842509832\ \(0\)\
\-\ metastatic\\:\\ 0\\.022763062472127938\ \(0\)\
\-\ abdominal\\:\\ 0\\.022602319980128203\ \(0\)\
\-\ unusual\\:\\ 0\\.021869773528266023\ \(0\)\
\-\ \\;\\:\\ 0\\.021433028449233796\ \(0\)\
\-\ uterus\\:\\ 0\\.02131231048245742\ \(0\)\
\-\ improvement\\:\\ 0\\.02109632109346136\ \(0\)\
\-\ urinary\\:\\ 0\\.020929661479390613\ \(0\)\
\-\ t\\:\\ 0\\.020929661479390613\ \(0\)\
\-\ mesenteric\\:\\ 0\\.02084825979240924\ \(0\)\
\-\ 19\\:\\ 0\\.02084825979240924\ \(0\)\
\-\ ovarian\\:\\ 0\\.020689119817608827\ \(0\)\
\-\ numerous\\:\\ 0\\.020274665620413555\ \(0\)\
\-\ their\\:\\ 0\\.01979018311498768\ \(0\)\
\-\ count\\:\\ 0\\.019659534371123277\ \(0\)\
\-\ 2\\:\\ 0\\.01947200525407985\ \(0\)\
\-\ al\\:\\ 0\\.01916699245013909\ \(0\)\
\-\ 40\\:\\ 0\\.01902202433274166\ \(0\)\
\-\ surgical\\:\\ 0\\.019007637780438662\ \(0\)\
\-\ i\\:\\ 0\\.018689495741949787\ \(0\)\
\-\ many\\:\\ 0\\.018583140295806468\ \(0\)\
\-\ et\\:\\ 0\\.018504753598530592\ \(0\)\
\-\ reports\\:\\ 0\\.01822688040126368\ \(0\)\
\-\ sagittal\\:\\ 0\\.018033580171991425\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01796287526293234\ \(0\)\
\-\ similar\\:\\ 0\\.017733791634607872\ \(0\)\
\-\ management\\:\\ 0\\.017061012928336727\ \(0\)\
\-\ pt\\:\\ 0\\.016810390236152127\ \(0\)\
\-\ pelvis\\:\\ 0\\.01642905506133137\ \(0\)\
\-\ elevated\\:\\ 0\\.015340298208249009\ \(0\)\
\-\ masses\\:\\ 0\\.015283557661354958\ \(0\)\
\-\ will\\:\\ 0\\.014145402213646253\ \(0\)\
\-\ such\\:\\ 0\\.014134035925083874\ \(0\)\
\-\ resection\\:\\ 0\\.01410008283344031\ \(0\)\
\-\ fat\\:\\ 0\\.013750858851225572\ \(0\)\
\-\ as\\:\\ 0\\.013678068845440506\ \(0\)\
\-\ only\\:\\ 0\\.013594770679814473\ \(0\)\
\-\ axial\\:\\ 0\\.012903658603533711\ \(0\)\
\-\ lesions\\:\\ 0\\.01210349474256057\ \(0\)\
\-\ \\:\\:\\ 0\\.01196058006339328\ \(0\)\
\-\ \\(\\:\\ 0\\.011466059146727945\ \(0\)\
\-\ \\)\\:\\ 0\\.011325995112909604\ \(0\)\
\-\ or\\:\\ 0\\.01059812432765828\ \(0\)\
\-\ imaging\\:\\ 0\\.010592983198177792\ \(0\)\
\-\ woman\\:\\ 0\\.010443930939094742\ \(0\)\
\-\ other\\:\\ 0\\.010421367982552637\ \(0\)\
\-\ demonstrate\\:\\ 0\\.010404508684301803\ \(0\)\
\-\ case\\:\\ 0\\.009891557845858575\ \(0\)\
\-\ findings\\:\\ 0\\.009623475850740526\ \(0\)\
\-\ multiple\\:\\ 0\\.009522783087191898\ \(0\)\
\-\ images\\:\\ 0\\.008673353925657958\ \(0\)\
\-\ \\,\\:\\ 0\\.008593970333882138\ \(0\)\
\-\ be\\:\\ 0\\.0069722577954705245\ \(0\)\
\-\ from\\:\\ 0\\.006700718059016996\ \(0\)\
\-\ an\\:\\ 0\\.006252195049125555\ \(0\)\
\-\ at\\:\\ 0\\.006125730967363137\ \(0\)\
\-\ year\\:\\ 0\\.00505875803848103\ \(0\)\
\-\ old\\:\\ 0\\.00462928358128177\ \(0\)\
\-\ to\\:\\ 0\\.0045192392427829235\ \(0\)\
\-\ a\\:\\ 0\\.004196823299667738\ \(0\)\
\-\ and\\:\\ 0\\.003809714407031078\ \(0\)\
\-\ with\\:\\ 0\\.002476278859045285\ \(0\)\
\-\ of\\:\\ 0\\.0024656889057775326\ \(0\)\
\-\ in\\:\\ 0\\.002229614974287063\ \(0\)\
\-\ \\.\\:\\ 0\\.0015026258665543396\ \(0\)\
\-\ the\\:\\ 0\\.0014629553936891617\ \(0\)\
